Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Frontiers in Neuroscience|January 9, 2014
Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulatorsAndres D Ramirez, Anthony L Gotter, Steven V Fox, et al.Journal of Neurogenetics|November 19, 2011
Pharmacological validation of candidate causal sleep genes identified in an N2 crossJoseph I Brunner, Anthony L Gotter, Joshua Millstein, et al.Plos One|April 11, 2009
Uncovering the genetic landscape for multiple sleep-wake traitsChristopher J Winrow, Deanna L Williams, Andrew Kasarskis, et al.The Journal of Clinical Investigation|May 20, 2009
Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in miceVictor N Uebele, Anthony L Gotter, Cindy E Nuss, et al.Bioorganic & Medicinal Chemistry Letters|November 13, 2013
Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs)Swati P Mercer, Anthony J Roecker, Susan Garson, et al.Bioorganic & Medicinal Chemistry Letters|January 24, 2015
Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacementsAnthony J Roecker, Swati P Mercer, Jeffrey M Bergman, et al.Brain Research|September 3, 2011
TASK-3 as a potential antidepressant targetAnthony L Gotter, Vincent P Santarelli, Scott M Doran, et al.Bioorganic & Medicinal Chemistry Letters|January 22, 2008
Proline bis-amides as potent dual orexin receptor antagonistsJeffrey M Bergman, Anthony J Roecker, Swati P Mercer, et al.Bioorganic & Medicinal Chemistry Letters|May 19, 2015
Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development propertiesScott D Kuduk, Jason W Skudlarek, Christina N DiMarco, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 1, 2013
Quantitative electroencephalography within sleep/wake states differentiates GABAA modulators eszopiclone and zolpidem from dual orexin receptor antagonists in ratsSteven V Fox, Anthony L Gotter, Spencer J Tye, et al.Pageof 12